the febs journals

Excellence in Bioscience Publishing

From The Federation of European Biochemical Societies

Discover the FEBS journals today!

• ViewFREE sample issues• Readthetop cited articles• Readthetopaccessed articles• SignupforFREE Content Alerting

The FEBS Journal is an international journal devoted to the rapid publication of full-length papers and reviews covering a broad spectrum of topics in the molecular life sciences. The FEBS Journal publishes in many areas including, but not limited to, structural biology, cell and molecular biology, immunology, bioinformatics, systems biology, genomics and proteomics, chemical biology, and the molecular basis of disease.

The FEBS Journal offers authors:

• Distinguished international Editorial Board

• Fast and helpful peer review

• No page charges and free colour figures

• Immediate free access to Reviews and Minireviews

• High visibility of published papers

• Open Access option

• Time to first decision normally less than 30 days

• The FEBS Journal Prize for Young Scientists

Keep up to date:

• Sign up for content alerts

• Read the latest articles published

• Read the most cited articles

• Read the most read articles

• Read the current sample copy

www.febsjournal.org

Special Issues

Frontiers in Cell Signalling, and Ca2+ Signalling and Transport in Health and Disease

Myogenesis

Catalytic Mechanisms by Biological Systems

Proteoglycans: Signaling, Targeting and Therapeutics

Read these and more at www.febsjournal.org

Enzyme Catalysis and Allostery: A Century of Advances in Molecular Understanding

Vol 281, Issue 2 (January 2014)

Edited by Athel Cornish-Bowden

Virtual Issues

MicroRNA

Systems Biology

Structural Biology

Molecular Enzymology

Read these and more at www.febsjournal.org

Epigenetics

November 2013

Edited by Pura Muñoz-Cánoves

Editor-in-Chief:SeamusMartinEditorialoffice:Cambridge,UK

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.

www.elsevier.com/locate/molonc

Molecular Oncology offers authors:

• No page charges and free colour

• Fast review time, less than 3 weeks

• Accepted articles published online within 5 days, to deliver your work to its audience as quickly as possible

• Connection with an audience of global cancer experts and stakeholders

• Comprehensive and constructive advice for improvements to papers

• Fully automated submission system, allowing you to track the progress of your paper

• Open Access options

Keep up to date:





• Read the open archive articles

Editor-in-Chief:J.E.CelisEditorialoffice:Copenhagen,Denmark

Special Issues Published Special Issues

Critical issues on biomarkers discovery and validation

Edited by Alan Spatz and Leon van Kempen

Drug resistance in cancer

Edited by Daniel Peeper

Innovative clinical trials for development of personalized cancer medicine

Edited by Ulrik Ringborg, Richard Schilsky, and John Mendelsohn

Mouse models of cancer: Essential tools for better therapies

Volume 7, Issue 2 (April 2013)

Edited by Mariano Barbacid and Anton Berns

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.

www.elsevier.com/locate/molonc

Molecular Oncology offers authors:

• No page charges and free colour

• Fast review time, less than 3 weeks

• Accepted articles published online within 5 days, to deliver your work to its audience as quickly as possible

• Connection with an audience of global cancer experts and stakeholders

• Comprehensive and constructive advice for improvements to papers

• Fully automated submission system, allowing you to track the progress of your paper


Keep up to date:






Editor-in-Chief:J.E.CelisEditorialoffice:Copenhagen,Denmark


Critical issues on biomarkers discovery and validation

Edited by Alan Spatz and Leon van Kempen

Drug resistance in cancer

Edited by Daniel Peeper

Innovative clinical trials for development of personalized cancer medicine

Edited by Ulrik Ringborg, Richard Schilsky, and John Mendelsohn

Mouse models of cancer: Essential tools for better therapies

Volume 7, Issue 2 (April 2013)

Edited by Mariano Barbacid and Anton Berns

www.elsevier.com/locate/febsopenbio

FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.

FEBS Open Bio offers authors:

• Easyonlinemanuscriptsubmissionand tracking system

• Fastandhelpfulpeerreview–mediantimetofirst decision 23 days in 2013

• TransferserviceforarticlesfromotherFEBSjournals, conserving peer reviews

• OpenAccesspublication

• AchoiceofCreativeCommonslicenses

• AllarticlesdepositedinPubMedCentralandindexed in PubMed

• HTMLenhancements,including3Dmolecularviewer

• Rapid,singlearticlepublication

Keep up to date:





ExecutiveEditor:MaryPurtonEditorialoffice:Cambridge,UK

www.elsevier.com/locate/febsopenbio

FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.

FEBS Open Bio offers authors:

• Easyonlinemanuscriptsubmissionand tracking system

• Fastandhelpfulpeerreview–mediantimetofirst decision 23 days in 2013

• TransferserviceforarticlesfromotherFEBSjournals, conserving peer reviews

• OpenAccesspublication

• AchoiceofCreativeCommonslicenses

• AllarticlesdepositedinPubMedCentralandindexed in PubMed

• HTMLenhancements,including3Dmolecularviewer

• Rapid,singlearticlepublication

Keep up to date:





ExecutiveEditor:MaryPurtonEditorialoffice:Cambridge,UK

FEBS Letters offers authors:

• Competent manuscript reviewing

• Easy online submission system

• No page charges and free colour figures


• Special Issues

• Fast-track manuscript handling

• Young Group Leader Award and Scientist Award

FEBS Letters is a world-renowned journal for the rapid publication of short reports describing novel and specific effects with a biologically or biochemically significant function. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum with high-quality Reviews on cutting-edge science, in addition to Research Letters and Hypotheses of broad interest.

www.elsevier.com/locate/febslet


Tumor Suppressors

Edited by Shairaz Baksh, Giovanni Blandino and Wilhelm Just

Gut Microbiome

Edited by Lloyd Kasper and Wilhelm Just

Single Molecule Fluorescence

Edited by Elias Puchner, Bo Huang and Herman Gaub

FEBS Congress, Paris Special Issue

Edited by Wilhelm Just

Junctional Proteins

Volume 588, Issue 8, April 2014

Edited by Michael Koval, Brant Isakson, Rob Gourdie and Wilhelm Just

Protein Engineering

Volume 588, Issue 2, January 2014

Edited by Wilhelm Just

Keep up to date:






ManagingEditor:FelixWielandEditorialoffice:Heidelberg,Germany

The Latest Results and Discussions Across the Molecular Life Sciences

• Esteemed international Editorial Boards

• High-quality peer review

• Research articles, reviews, Special Issues, Virtual Issues and more

• Fast publication

• Innovative features including database linking, structured digital abstracts, enhanced html access and podcasts

• Highly cited and highly accessed content


Awards for Outstanding Papers – Read all about it!• The FEBS Journal Prize bit.ly/FEBSJprize

• FEBS Letters Award bit.ly/FEBSLprize

FEBS is a charitable organization advancing research in the molecular life sciences across Europe and beyond. The publications are wholly owned by FEBS, and income from them funds FEBS programmes such as fellowships and courses.

FEBS is celebrating its 50th anniversary in 2014. Find out more at www.febs.org

Excellence in Bioscience Publishing

From The Federation of European Biochemical Societies

Discover the FEBS journals today!

• ViewFREE sample issues• Readthetop cited articles• Readthetopaccessed articles• SignupforFREE Content Alerting

The Latest Results and Discussions Across the Molecular Life Sciences

• Esteemed international Editorial Boards

• High-quality peer review

• Research articles, reviews, Special Issues, Virtual Issues and more

• Fast publication

• Innovative features including database linking, structured digital abstracts, enhanced html access and podcasts

• Highly cited and highly accessed content


Awards for Outstanding Papers – Read all about it!• The FEBS Journal Prize bit.ly/FEBSJprize

• FEBS Letters Award bit.ly/FEBSLprize

FEBS is a charitable organization advancing research in the molecular life sciences across Europe and beyond. The publications are wholly owned by FEBS, and income from them funds FEBS programmes such as fellowships and courses.

FEBS is celebrating its 50th anniversary in 2014. Find out more at www.febs.org

14

-6

63

44

the febs journals

Documents

read articles

cited articles

latest articles

international journal

cancer issues

febs journal prize

molecular biology

febs journals